The impact of aerobic exercise training on novel adipokines, apelin and ghrelin, in patients with type 2 diabetes

Medical Science Monitor

Volumn 18, Issue 5, 2012, Pages

  Kadoglou, Nikolaos P E ^a,b   Vrabas, Ioannis S ^b   Kapelouzou, Alkistis ^c   Lampropoulos, Stylianos ^b   Sailer, Nikolaos ^a   Kostakis, Alkiviadis ^c   Liapis, Christos D ^d   Angelopoulou, Nikoletta ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Aristotle University of Thessaloniki   (Greece)

^c BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^d UNIVERSITY OF ATHENS   (Greece)

Author keywords

Adipokines; Apelin; Exercise; Ghrelin; Type 2 diabetes

Indexed keywords

ADIPOCYTOKINE; APELIN; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GHRELIN; GLUCOSE; INSULIN; LIPID; METFORMIN; SULFONYLUREA;

AEROBIC EXERCISE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CYCLING; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; KINESIOTHERAPY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RUNNING; SEX DIFFERENCE; TREADMILL EXERCISE; WAIST HIP RATIO; WALKING;

EID: 84860685942     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.882734     Document Type: Article

References (30)

1. Bonaterra GA, Zügel S, Kinscherf R: Novel systemic cardiovascular disease biomarkers. Curr Mol Med, 2010; 10: 180-205
2. Kadoglou NP, Avgerinos ED, Liapis CD: An update on markers of carotid atherosclerosis in patients with type 2 diabetes. Biomark Med, 2010; 4: 601-609
3. Soriguer F, Garrido-Sanchez L, Garcia-Serrano S et al: Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obes Surg, 2009; 19: 1574-1580
4. Carpéné C, Dray C, Attané C et al: Expanding role for the apelin/APJ system in physiopathology. J Physiol Biochem, 2007; 63: 359-373
5. Kadoglou NP, Lampropoulos S, Kapelouzou A et al: Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease - KOZANI STUDY. Transl Res, 2010; 155: 238-246
6. Kuklinska AM, Sobkowicz B, Sawicki R et al: Apelin: a novel marker for the patients with first ST-elevation myocardial infarction. Heart Vessels, 2010; 25: 363-367
7. Tasci I, Erdem G, Ozgur G et al: LDL-cholesterol lowering increases plasma apelin in isolated hypercholesterolemia. Atherosclerosis, 2009; 204: 222-228
8. Kadoglou NP, Tsanikidis H, Kapelouzou A et al: Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus. Metabolism, 2010; 59: 373-379
9. García EA, Korbonits M: Ghrelin and cardiovascular health. Curr Opin Pharmacol, 2006; 6: 142-147
10. Ukkola O, Poykko S, Paivansalo M, Kesaniemi YA: Interactions between ghrelin, leptin and IGF-I affect metabolic syndrome and early atherosclerosis. Ann Med, 2008: 1-9
11. Yano Y, Toshinai K, Inokuchi T et al: Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients. Atherosclerosis, 2009; 204: 590-594
12. Kadoglou NP, Sailer N, Moumtzouoglou A et al: Novel markers of carotid atherosclerosis in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes, 2010; 118: 75-80
13. Sigal RJ, Kenny GP, Wasserman DH et al: Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care, 2006; 29: 1433-1438
14. Telford RD: Low physical activity and obesity: causes of chronic disease or simply predictors? Med Sci Sports Exerc, 2007; 39(8): 1233-1240
15. Kadoglou NP, Iliadis F, Angelopoulou N et al: The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus. Eur J Cardiovasc Prev Rehabil, 2007; 14: 837-843
16. Buse JB, Ginsberg HN, Bakris GL et al, American Heart Association; American Diabetes Association: Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care, 2007; 30: 162-172
17. Kadoglou NP, Iliadis F, Liapis CD et al: Beneficial effects of combined treatment with rosiglitazone and exercise on cardiovascular risk factors in patients with type 2 diabetes. Diabetes Care, 2007; 30: 2242-2244
18. Quazi R, Palaniswamy C, Frishman WH: The emerging role of apelin in cardiovascular disease and health. Cardiol Rev, 2009; 17: 283-286
19. Dray C, Debard C, Jager J et al: Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans. Am J Physiol Endocrinol Metab, 2010; 298: E1161-E1169
20. Kelly M, Gauthier MS, Saha AK, Ruderman NB: Activation of AMPactivated protein kinase by interleukin-6 in rat skeletal muscle: association with changes in cAMP, energy state, and endogenous fuel mobilization. Diabetes, 2009; 58: 1953-1960
21. Erdem G, Dogru T, Tasci I et al: Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes, 2008; 116: 289-292
22. Cummings DE: Ghrelin and the short- and long-term regulation of appetite and body weight. Physiol Behav, 2006; 89: 71-84
23. Adams CE, Greenway FL, Brantley PJ: Lifestyle factors and ghrelin: critical review and implications for weight loss maintenance. Obes Rev, 2011; 12(5): e211-e218
24. Pöykkö SM, Kellokoski E, Horkko S et al: Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes, 2003; 52: 2546-2553
25. Dezaki K, Sone H, Yada T: Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis. Pharmacol Ther, 2008; 118: 239-249
26. Ueno H, Shiiya T, Mizuta M et al: Plasma ghrelin concentrations in different clinical stages of diabetic complications and glycemic control in Japanese diabetics. Endocr J, 2007; 54: 895-902
27. Littman AJ, Vitiello MV, Foster-Schubert K et al: Sleep, ghrelin, leptin and changes in body weight during a 1-year moderate-intensity physical activity intervention. Int J Obes, 2007; 31: 466-475
28. Hagobian TA, Sharoff CG, Stephens BR et al: Effects of exercise on energy-regulating hormones and appetite in men and women. Am J Physiol Regul Integr Comp Physiol, 2009; 296: R233-R242
29. Gayle DA, Desai M, Casillas E et al: Gender-specific orexigenic and anorexigenic mechanisms in rats. Life Sci, 2006; 79: 1531-1536
30. Nedungadi TP, Clegg DJ: Sexual dimorphism in body fat distribution and risk for cardiovascular diseases. J Cardiovasc Transl Res, 2009; 2: 321-327